Repligen Corporation (RGEN)

Repligen Market Cap

Repligen has a market cap or net worth of $6.92 billion as of July 22, 2024. Its market cap has decreased by -11.90% in one year.

• Market Cap: 6.92B
• Enterprise Value: 6.88B
• 1-Year Change: -11.90%
• Ranking: #1056
• Category: Mid-Cap
• Stock Price: $123.81

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $6.92B, an increase of 24,519.20%. That is a compound annual growth rate of 23.95%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	6.92B	-31.09%
Dec 29, 2023	10.04B	6.78%
Dec 30, 2022	9.40B	-35.80%
Dec 31, 2021	14.64B	45.21%
Dec 31, 2020	10.08B	109.40%
Dec 31, 2019	4.82B	108.18%
Dec 31, 2018	2.31B	46.35%
Dec 29, 2017	1.58B	51.58%
Dec 30, 2016	1.04B	11.88%
Dec 31, 2015	932.00M	43.85%
Dec 31, 2014	647.90M	48.87%
Dec 31, 2013	435.20M	122.72%
Dec 31, 2012	195.40M	83.30%
Dec 30, 2011	106.60M	-26.18%
Dec 31, 2010	144.40M	14.24%
Dec 31, 2009	126.40M	7.21%
Dec 31, 2008	117.90M	-41.78%
Dec 31, 2007	202.50M	137.12%
Dec 29, 2006	85.40M	-29.07%
Dec 30, 2005	120.40M	39.03%
Dec 31, 2004	86.60M	-33.64%
Dec 31, 2003	130.50M	57.04%
Dec 31, 2002	83.10M	28.04%
Dec 31, 2001	64.90M	-27.65%
Dec 29, 2000	89.70M	28.51%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Ascendis Pharma	7.65B
Revolution Medicines	7.61B
Penumbra	7.36B
Blueprint Medicines	7.20B
Ionis Pharmaceuticals	6.98B
Halozyme Therapeutics	6.88B
Jazz Pharmaceuticals	6.87B
Tempus AI	6.82B